Tecelra Approved to Fight Rare Cancer That Hits Young Adults

WEDNESDAY, Aug. 7, 2024 -- A new immunotherapy is now available to treat a rare soft tissue cancer that most frequently occurs in young men.

The U.S. Food and Drug Administration has granted accelerated approval to Tecelra (afamitresgene...